Literature DB >> 8084608

A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1.

M Chedid1, P Michieli, C Lengel, K Huppi, D Givol.   

Abstract

The recently discovered WAF1/CIP1 gene is a mediator of p53 tumor suppressor activity. To analyse WAF1/CIP1 for possible mutations, polymerase chain reaction (PCR) amplified cDNAs from several tumor cell lines were cloned and sequenced. A single point mutation which changes codon 31 from AGC to AGA (Ser to Arg) was found. This change resulted in the loss of a Bpu1102I and gain of an Esp3I restriction site, allowing for rapid screening of this mutation in human DNAs. Analysis of genomic DNAs from 50 randomly selected individuals revealed that this base pair substitution represents a polymorphism with an allelic frequency of 0.14. Transfection studies demonstrated that the expression of the Arg allele of WAF1/CIP1 was not associated with loss of tumor suppressor activity. Moreover, screening of 22 tumor DNA samples revealed no association between the tumor phenotype and the Arg allele of WAF1/CIP1 (two out of 22 tumor DNAs contained the Arg31 allele). This polymorphism will be a useful molecular marker in the analysis of loss of heterozygosity in human cancers, and further studies using a larger panel of tumors may reveal an association between this polymorphism and specific types of cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8084608

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

Review 1.  Single-nucleotide polymorphisms in the p53 signaling pathway.

Authors:  Lukasz F Grochola; Jorge Zeron-Medina; Sophie Mériaux; Gareth L Bond
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

2.  Analysis of the p21 gene in gliomas.

Authors:  Y J Li; K Hoang-Xuan; X P Zhou; M Sanson; K Mokhtari; T Faillot; P Cornu; M Poisson; G Thomas; R Hamelin
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

3.  Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study.

Authors:  Ana Souto-García; Ana Fernández-Somoano; Teresa Pascual; Sara M Álvarez-Avellón; Adonina Tardón
Journal:  Lung Cancer (Auckl)       Date:  2012-11-21

4.  Aberrant promoter hypermethylation of p21 (WAF1/CIP1) gene and its impact on expression and role of polymorphism in the risk of breast cancer.

Authors:  Marjan Askari; Ranbir Chander Sobti; Mohsen Nikbakht; Suresh C Sharma
Journal:  Mol Cell Biochem       Date:  2013-09-05       Impact factor: 3.396

5.  Absence of p21 WAF1 and p27 kip1 gene mutations in various feline tumours.

Authors:  B Mayr; B Wilhelm; M Reifinger; G Brem
Journal:  Vet Res Commun       Date:  2000-03       Impact factor: 2.459

6.  Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer.

Authors:  Jinyun Chen; Ann M Killary; Subrata Sen; Christopher I Amos; Douglas B Evans; James L Abbruzzese; Marsha L Frazier
Journal:  Cancer Lett       Date:  2008-08-09       Impact factor: 8.679

Review 7.  Inhibitors of cyclin-dependent kinase and cancer.

Authors:  J R Biggs; A S Kraft
Journal:  J Mol Med (Berl)       Date:  1995-10       Impact factor: 4.599

8.  Association of p53 and p21 polymorphisms with prostate cancer.

Authors:  Monika Kmeťová Sivoňová; Marta Vilčková; Ján Kliment; Silvia Mahmood; Jana Jurečeková; Svetlana Dušenková; Iveta Waczulíková; Peter Slezák; Dušan Dobrota
Journal:  Biomed Rep       Date:  2015-07-27

9.  Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas.

Authors:  A A Ferrando; M Balbín; A M Pendás; F Vizoso; G Velasco; C López-Otín
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

10.  The effects of p21 gene C98A polymorphism on development of uterine leiomyoma in southeast Iranian women.

Authors:  Saeedeh Salimi; Azam Hajizadeh; Minoo Yaghmaei; Sodabeh Rezaie; Mahnaz Shahrakypour; Batool Teimoori; Mahboube Parache; Anoosh Naghavi; Mojgan Mokhtari
Journal:  Tumour Biol       Date:  2016-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.